Table 2 Prevalence of sarcopenia and bone disease in patients with HCV-related cirrhosis and control participants
From: Evaluation of handgrip strength as a predictor of sarcopenia in patients with HCV-related cirrhosis
|  | Cirrhosis group | Control group (n = 32) | p-value | ||
|---|---|---|---|---|---|
Total (n = 32) | Child A (n = 16) | Child C (n = 16) | |||
n (%) | n (%) | n (%) | n (%) | Â | |
Sarcopenia | |||||
 No | 21 (65.6%) | 14 (87.5%) | 7 (43.8%) | 30 (93.8%) | < 0.001 |
 Yes | 11 (34.4%) | 2 (12.5%) | 9 (56.3%) | 2 (6.3%) | |
DEXA-BMD | |||||
 Normal | 2 (6.3%) | 2 (12.5%) | 0 (0.0%) | 13 (40.6%) | < 0.001 |
 Osteopenia | 18 (56.3%) | 9 (56.3%) | 9 (56.3%) | 15 (46.9%) | |
 Osteoporosis | 12 (37.5%) | 5 (31.3%) | 7 (43.8%) | 4 (12.5%) | |